Table 14Change in World Health Organization Functional Class

VisitWHO
Functional
Class		Riociguat (n = 173)Placebo (n = 88)
Baselinen▬▬▬▬▬▬▬▬
I▬▬▬▬▬▬▬▬
II▬▬▬▬▬▬▬▬
III▬▬▬▬▬▬▬▬
IV▬▬▬▬▬▬▬▬
Last Visitn▬▬▬▬▬▬▬▬
I▬▬▬▬▬▬▬▬
II▬▬▬▬▬▬▬▬
III▬▬▬▬▬▬▬▬
IV▬▬▬▬▬▬▬▬
Va▬▬▬▬▬▬▬▬
Change From Baseline at Last Visitn▬▬▬▬▬▬▬▬
−2▬▬▬▬▬▬▬▬
−1▬▬▬▬▬▬▬▬
0▬▬▬▬▬▬▬▬
1▬▬▬▬▬▬▬▬
2▬▬▬▬▬▬▬▬
3▬▬▬▬▬▬▬▬
P value (stratified Wilcoxon test)▬▬▬▬

WHO = World Health Organization.

a

V represented an imputed worst value in case of death.

From: APPENDIX 4, DETAILED OUTCOME DATA

Cover of Riociguat (Adempas)
Riociguat (Adempas): Management of Inoperable Chronic Thromboembolic Pulmonary Hypertension [Internet].
Copyright © CADTH 2015.

You are permitted to make copies of this document for non-commercial purposes, provided it is not modified when reproduced and appropriate credit is given to CADTH. You may not otherwise copy, modify, translate, post on a website, store electronically, republish, or redistribute any material from this document in any form or by any means without the prior written permission of CADTH.

Please contact CADTH’s Vice-President of Corporate Services at ac.htdac@secivresetaroproc with any inquiries about this notice or other legal matters relating to CADTH’s services.

Except where otherwise noted, this work is distributed under the terms of a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International licence (CC BY-NC-ND), a copy of which is available at http://creativecommons.org/licenses/by-nc-nd/4.0/

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.